AFC-HD AMS Life Science Co.,Ltd. Logo

AFC-HD AMS Life Science Co.,Ltd.

An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.

2927 | T

Overview

Corporate Details

ISIN(s):
JP3124700000
LEI:
Country:
Japan
Address:
静岡市駿河区豊田3丁目6番36号

Description

AFC-HD AMS Life Science Co., Ltd. is a comprehensive Original Equipment Manufacturer (OEM) specializing in the development, manufacturing, and sale of health foods, dietary supplements, and cosmetics. The company operates across both the healthcare and pharmaceutical business segments. Through its group subsidiaries, it manages a vertically integrated model encompassing research and development, GMP-certified production, and distribution channels such as mail-order sales and wholesale. Key activities include the R&D of innovative supplements through its preventive medical laboratory and the creation of health-related media content. The company delivers a wide spectrum of quality products to meet diverse customer needs.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-26 08:39
確認書
Japanese 8.9 KB
2025-11-26 08:38
有価証券報告書-第45期(2024/09/01-2025/08/31)
Japanese 1.2 MB
2025-07-15 08:30
有価証券届出書(組込方式)
Japanese 260.6 KB
2025-04-14 08:33
確認書
Japanese 8.9 KB
2025-04-14 08:32
半期報告書-第45期(2024/09/01-2025/08/31)
Japanese 271.0 KB
2025-02-07 02:18
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.9 KB
2024-11-28 07:36
臨時報告書
Japanese 28.8 KB
2024-11-27 07:34
内部統制報告書-第44期(2023/09/01-2024/08/31)
Japanese 24.0 KB
2024-11-27 07:33
確認書
Japanese 8.9 KB
2024-11-27 07:32
有価証券報告書-第44期(2023/09/01-2024/08/31)
Japanese 1.2 MB
2024-11-21 03:12
臨時報告書
Japanese 24.5 KB
2024-07-16 08:02
確認書
Japanese 8.9 KB
2024-07-16 08:02
四半期報告書-第44期第3四半期(2024/03/01-2024/05/31)
Japanese 211.7 KB
2024-04-15 08:08
確認書
Japanese 8.9 KB
2024-04-15 08:07
四半期報告書-第44期第2四半期(2023/12/01-2024/02/29)
Japanese 268.2 KB

Automate Your Workflow. Get a real-time feed of all AFC-HD AMS Life Science Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for AFC-HD AMS Life Science Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for AFC-HD AMS Life Science Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.